TABLE 1.
Demographics | Control | Schizophrenia | t/U/χ 2 (df) | P-value |
(n = 69) | (n = 72) | |||
Age in years ± s.d. | 48.01 ± 12.17 | 47.07 ± 12.45 | t(139) = 0.46 | 0.65 |
Sex | 16F:53M | 22F:50M | χ2(1) = 0.97 | 0.32 |
Hemisphere | 40R:29L | 35R:37L | χ2(1) = 1.24 | 0.27 |
Brain pH ± s.d. | 6.63 ± 0.28 | 6.55 ± 0.28 | t(139) = 1.85 | 0.067 |
PMI (hours) ± s.d. | 27.15 ± 12.31 | 29.93 ± 14.63 | U = 2225.00 | 0.29 |
RIN ± s.d. | 7.73 ± 0.79 | 7.85 ± 0.83 | t(139) = 0.92 | 0.36 |
Age (years) at onset ± s.d. | − | 22.53 ± 6.15 | − | − |
Duration of illness (years) ± s.d. | − | 24.54 ± 12.50 | − | − |
Chlorpromazine mean equivalent daily dose (mg) ± s.d. | − | 616.03 ± 502.71 | − | − |
PMI, postmortem interval; RIN, RNA integrity number.